Alle Storys
Keine Meldung von aap Implantate AG mehr verpassen.

30.11.2000 – 06:23

aap Implantate AG

ots Ad hoc-Service: aap Implantate AG Acquiring Coripharm, Mebio and Corimed plus 49% stake in Osartis, aap Implantate AG expands into promising orthobiology sector

Ad hoc-announcement edited and sent by DGAP. The sender is solely responsible for the contents of this announcement. ----------------------------------------------------

    Berlin (ots Ad hoc-Service) -      
    Acquiring Coripharm, Mebio and Corimed plus 49% stake in Osartis,
aap Implantate AG expands into promising orthobiology sector

    aap Implantate AG, one of the leading German companies in the
biomedical implant sector, is expanding the promising biological
implant business field. It has acquired 100% of Coripharm, Mebio and
Corimed, based in Dieburg, Germany, and a 49% stake in Obernburg-
based, Germany, Osartis. The four companies are involved in
biological bone substitute, osteosynthesis, endoprosthetics and local

    For aap, these acquisitions and holdings in Germany represent a crucial step toward becoming an all-round supplier in the orthopaedics market. Its core business fields have hitherto been osteosynthesis (bone fracture healing), and endoprosthetics, (joint replacements). The acquisition now takes aap forward into a third sector: orthobiology (biological implants). Alongside additional innovative products, aap has now acquired, via these acquisitions and holdings, a research team with long years of experience, a total of 17 patents in the above-mentioned business fields and an international network of recognized research scientists and practical, working physicians.

    The six companies in which aap is now a shareholder were previously separate and independent companies both legally and organisationally. Between them, with a staff of about 30, they achieved a turnover of roughly DM 8.3 million in 1999. They are, in detail:

    - Coripharm Medizinprodukte GmbH & Co. KG (research and product development for endoprosthetics, bone substitutes and local wound healing)

    - Coripharm Medizinprodukte-Verwaltungs GmbH (partnership company) - Mebio Medizintechnische Biomaterialien GmbH (sales and administration for the above-mentioned products) - Corimed Kundenorientierte Medizinprodukte GmbH (parent company of Mebio Medizintechnische Biomaterialien GmbH) - Osartis GmbH & Co. KG (developing and manufacturing bone substitute materials)

    - Osartis Verwaltungs-GmbH (partnership company)

    aap Implantate AG expects, in addition to moving forward into orthobiology, to gain considerable growth potential from widening its product range and integrating the sales structures and the manufacturing capacities.

    If you have any queries, please contact:

    aap Implantate AG

    Bruke Seyoum Alemu Gabriele Voßkühler Member of the Board of Management Investor Relations Finance and Information Technology Lorenzweg 5 Lorenzweg 5

    12099 Berlin 12099 Berlin

    Tel: +49 (0)30 / 750 19-170 Tel.: +49 (0)30 / 750 19-133 Fax: +49 (0)30 / 750 19-111 Tel.: +49 (0)30 / 750 19-111

End ----------------------------------------------------- Internet:

Original-Content von: aap Implantate AG, übermittelt durch news aktuell